Roll Cannabis Group

Roll Cannabis Group "RCG" has completed the acquisition of FXO Legend Grown and its existing brands, and thereby add operations in California, Nevada, Florida and New York to its existing Canadian platform. The combination of cannabis cultivation know-how and FXO’s extensive pharmaceutical experience, consulting, and operations management along with its marketing brands, creates tremendous value. With an expected annual capacity of kilograms, the RCG cultivation asset in Canada should allow us to be a significant producer in the global medical cannabis and active pharmaceutical ingredient (API) markets, initially in Canada and North America. We continue to see the cannabis market bifurcating into premium, superior quality adult use products, where legal, and a global medical opportunity that will require massive production scale and deep GMP expertise. With the completion of this acquisition, the subsequent ramp-up of production at RCG, and the continued buildout of our campus in California, Roll Cannabis Group is strategically positioned to service the global cannabis market from an efficient footprint.